Expertise in
38
conditions

Dr. William T. Curry

Neurosurgery
Massachusetts General Hospital
55 Fruit St, 
Boston, MA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
38
conditions
Massachusetts General Hospital
55 Fruit St, 
Boston, MA 

Overview

William Curry is a Neurosurgery provider practicing medicine in Boston, Massachusetts.

Dr. Curry is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Meningioma, Awake Craniotomy, and Septoplasty.

He is actively involved in clinical research, co-authoring 160 peer reviewed articles and participating in 9 clinical trials. Dr. Curry is currently accepting new patients.

Specialties

Neurosurgery

Licenses

Neurological Surgery in MA

Hospital Affiliations

Massachusetts General Hospital
Brigham And Women's Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Tufts
  • HMO

Locations

Massachusetts General Hospital
55 Fruit St, Boston, MA 02114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Long-term Follow-up of Subjects Treated With CAR T Cells
Long-term Follow-up of Subjects Treated With CAR T Cells
Enrollment Status: Recruiting
Publish Date: March 16, 2026
Intervention Type: Diagnostic test, Procedure
A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed Glioblastoma
A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Biological, Drug, Other
Study Drugs: Montanide ISA 51 VG, Sargramostim, SVN53-67/M57-KLH Peptide Vaccine, Temozolomide
Study Phase: Phase 2
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
Enrollment Status: Completed
Publish Date: July 11, 2025
Intervention Type: Biological, Drug
Study Drug: Oncolytic Polio/Rhinovirus Recombinant Vaccine
Study Phase: Phase 2
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: June 05, 2025
Intervention Type: Biological
Study Drugs: PVSRIPO, Pembrolizumab
Study Phase: Phase 2
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
Enrollment Status: Completed
Publish Date: April 28, 2020
Intervention Type: Radiation, Other, Biological
Study Phase: Not Applicable
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Enrollment Status: Completed
Publish Date: June 22, 2017
Intervention Type: Biological
Study Phase: Phase 1
View 7 Less Clinical Trials

160 Total Publications

Next-generation CAR-NK cell therapy for glioblastoma: strategies to overcome antigen escape and the immunosuppressive tumor microenvironment.
Next-generation CAR-NK cell therapy for glioblastoma: strategies to overcome antigen escape and the immunosuppressive tumor microenvironment.
Journal: Expert opinion on biological therapy
Published: May 11, 2026
Similar Doctors
Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

Beth Israel Deaconess Medical Center

110 Francis Street, 
Boston, MA 
 (2.8 miles away)
617-632-7246
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Ogilvy is a Neurosurgery provider practicing medicine in Boston, Massachusetts. Dr. Ogilvy is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Arteriovenous Malformation, Chronic Subdural Hematoma, Craniectomy, and Endovascular Embolization. Dr. Ogilvy is board certified in American Board Of Neurological Surgery. Dr. Ogilvy is currently accepting new patients.

Expertise in
22
conditions
Dr. Aman B. Patel
Neurosurgery
Expertise in
22
conditions
Dr. Aman B. Patel
Neurosurgery
Referral may be required

Carlos Fernandez-Del Castillo MD

15 Parkman St, 
Boston, MA 
 (0.1 miles away)
617-726-3303
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Aman Patel is a Neurosurgery provider practicing medicine in Boston, Massachusetts. Dr. Patel is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Subarachnoid Hemorrhage, Stroke, Thrombectomy, and Extracranial-Intracranial Bypass Surgery. Dr. Patel is currently accepting new patients.

Expertise in
39
conditions
Dr. Wenya L. Bi
Neurosurgery
Expertise in
39
conditions
Dr. Wenya L. Bi
Neurosurgery
Referral may be required

Brigham And Women's Hospital, Neurosciences Center

60 Fenwood Rd # 1, 
Boston, MA 
 (2.6 miles away)
617-732-6600
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Wenya Bi is a Neurosurgery provider practicing medicine in Boston, Massachusetts. Dr. Bi is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Meningioma, Brain Tumor, Astrocytoma, Awake Craniotomy, and Nerve Decompression. Dr. Bi is currently accepting new patients.

Frequently Asked Questions about Dr. William T. Curry

How do I make an appointment with Dr. William T. Curry?

You can book an appointment with Dr. William T. Curry by calling their office at 617-726-3779. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. William T. Curry a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. William T. Curry is classified as an Elite expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. William T. Curry specialize in?

While Dr. William T. Curry is a Neurosurgery, they have specific expertise in Astrocytoma, Glioblastoma, and Meningioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. William T. Curry participate in research or clinical trials?

Yes. Dr. William T. Curry has published 160 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. William T. Curry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. William T. Curry accept my insurance?

Dr. William T. Curry accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 617-726-3779 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Curry's expertise for a condition
ConditionClose
View All 16 Distinguished Conditions
View All 16 Advanced Conditions
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile